NL189648C - Farmaceutisch preparaat met werking op het centrale zenuwstelsel op basis van 3-(3,4-dihydroxyfenyl)-serine en een decarboxylase-remmer. - Google Patents

Farmaceutisch preparaat met werking op het centrale zenuwstelsel op basis van 3-(3,4-dihydroxyfenyl)-serine en een decarboxylase-remmer.

Info

Publication number
NL189648C
NL189648C NLAANVRAGE8203594,A NL8203594A NL189648C NL 189648 C NL189648 C NL 189648C NL 8203594 A NL8203594 A NL 8203594A NL 189648 C NL189648 C NL 189648C
Authority
NL
Netherlands
Prior art keywords
dihydroxyphenyl
serine
system based
nervous system
central nervous
Prior art date
Application number
NLAANVRAGE8203594,A
Other languages
English (en)
Dutch (nl)
Other versions
NL8203594A (nl
NL189648B (nl
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of NL8203594A publication Critical patent/NL8203594A/nl
Publication of NL189648B publication Critical patent/NL189648B/xx
Application granted granted Critical
Publication of NL189648C publication Critical patent/NL189648C/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NLAANVRAGE8203594,A 1981-09-22 1982-09-16 Farmaceutisch preparaat met werking op het centrale zenuwstelsel op basis van 3-(3,4-dihydroxyfenyl)-serine en een decarboxylase-remmer. NL189648C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56150082A JPS5852219A (ja) 1981-09-22 1981-09-22 パ−キンソン病治療剤
JP15008281 1981-09-22

Publications (3)

Publication Number Publication Date
NL8203594A NL8203594A (nl) 1983-04-18
NL189648B NL189648B (nl) 1993-01-18
NL189648C true NL189648C (nl) 1993-06-16

Family

ID=15489114

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE8203594,A NL189648C (nl) 1981-09-22 1982-09-16 Farmaceutisch preparaat met werking op het centrale zenuwstelsel op basis van 3-(3,4-dihydroxyfenyl)-serine en een decarboxylase-remmer.

Country Status (13)

Country Link
US (1) US4497826A (enExample)
JP (1) JPS5852219A (enExample)
AU (2) AU556542B2 (enExample)
BE (1) BE894451A (enExample)
CA (1) CA1184501A (enExample)
CH (1) CH650926A5 (enExample)
DE (1) DE3235093A1 (enExample)
FR (1) FR2513117B1 (enExample)
GB (1) GB2106388B (enExample)
IT (1) IT1212668B (enExample)
NL (1) NL189648C (enExample)
NZ (1) NZ201864A (enExample)
SE (1) SE462781B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6067420A (ja) * 1983-09-22 1985-04-17 Sumitomo Chem Co Ltd 精神運動興奮抑制剤
AU575849B2 (en) * 1983-09-22 1988-08-11 Sumitomo Chemical Company, Limited Pharmaceutical composition and method for treatment of psychomotor excitement
NZ209514A (en) * 1983-09-22 1988-03-30 Sumitomo Chemical Co Pharmaceutical compositions containing erythro-3,4-dihydroxyphenylserine and a decarboxylase inhibitor
JPS60132935A (ja) * 1983-12-20 1985-07-16 Sumitomo Chem Co Ltd フエニルセリン誘導体及びその製造方法
JPS6185318A (ja) * 1984-10-04 1986-04-30 Sumitomo Seiyaku Kk 利尿薬
ZA889189B (en) * 1986-06-16 1989-08-30 Merck & Co Inc Controlled release combination of carbidopa/levodopa
US4832957A (en) * 1987-12-11 1989-05-23 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
US4983400A (en) * 1986-06-16 1991-01-08 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
US4863962A (en) * 1988-03-02 1989-09-05 Fidia-Georgetown Institute For The Neurosciences D-DOPA, pharmaceutically acceptable salts thereof, and methods of treating Parkinson's disease
PT99864B (pt) * 1990-12-21 1999-06-30 Schering Ag Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato
DE4101873C2 (de) 1991-01-23 1993-12-09 Isis Pharma Gmbh Peroral applizierbare Arzneiform zur Behandlung zentraler Dopaminmangelzustände
JP3559572B2 (ja) 1993-01-29 2004-09-02 住友製薬株式会社 急性痛および慢性痛用鎮痛剤
JP3764179B2 (ja) * 1994-07-05 2006-04-05 克寛 西野 運動・意識または言語障害の機能改善剤
US5668114A (en) * 1996-05-08 1997-09-16 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating hypertension
GB2348371B (en) * 2000-03-14 2001-04-04 Soares Da Silva Patricio Compositions comprising blockers of L-DOPA renal cell transfer for the treatment of Parkinson's disease
US8158149B2 (en) * 2004-05-12 2012-04-17 Chelsea Therapeutics, Inc. Threo-DOPS controlled release formulation
WO2004100929A1 (en) 2003-05-12 2004-11-25 Synergia Pharma, Inc. Threo-dops controlled release formulation
US20070010584A1 (en) * 2003-09-04 2007-01-11 Peroutka Stephen J Compositions and methods for orthostatic intolerance
US8007827B2 (en) * 2004-04-02 2011-08-30 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties
US7786126B2 (en) * 2006-06-16 2010-08-31 Solvay Pharmaceuticals B.V. Combination preparations comprising SLV308 and a dopamine agonist
ES2571730T3 (es) * 2006-06-28 2016-05-26 Lundbeck Na Ltd Composiciones farmacéuticas que comprenden droxidopa
AU2008226541B2 (en) * 2007-03-09 2013-05-09 Chelsea Therapeutics, Inc. Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgia
EP2167066B1 (en) * 2007-05-07 2013-06-26 Chelsea Therapeutics, Inc. Droxidopa and pharmaceutical composition thereof for the treatment of attention deficit disorders
US8580776B2 (en) * 2007-07-10 2013-11-12 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating neurodegenerating diseases
JPWO2011001976A1 (ja) 2009-07-01 2012-12-13 大日本住友製薬株式会社 スレオ−3−(3,4−ジヒドロキシフェニル)−l−セリンの製造法
JP5880913B2 (ja) 2011-05-17 2016-03-09 三郎 佐古田 パーキンソン病の体幹症状(姿勢反射異常)の治療剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL34687A (en) * 1969-06-18 1973-07-30 Merck & Co Inc Compounds of a-hydrazino-b-acid (3,4-dihydroxyphenyl) -a-converted propionate
US3658968A (en) * 1970-06-11 1972-04-25 Merck & Co Inc Composition and method of treatment
DE2305209A1 (de) * 1972-02-14 1973-08-23 Hoffmann La Roche Pharmazeutisches praeparat
AU6889274A (en) * 1973-05-17 1975-11-20 Astra Laekemedel Ab Treatment of neurological disorders
CH580059A5 (enExample) * 1973-08-22 1976-09-30 Hoffmann La Roche
US3920728A (en) * 1973-08-22 1975-11-18 Hoffmann La Roche Separation and resolution of isomeric forms of 3-(3,4-dihydroxy-phenyl)-serine
JPS52125630A (en) * 1976-04-14 1977-10-21 Kyowa Hakko Kogyo Co Ltd Antiperkinson drugs containing l-threo-3,4-dihydroxyphenylserine
JPS56104815A (en) * 1980-01-23 1981-08-20 Sumitomo Chem Co Ltd Remedy for peripheral orthostatic hypotension

Also Published As

Publication number Publication date
CA1184501A (en) 1985-03-26
IT1212668B (it) 1989-11-30
JPS5852219A (ja) 1983-03-28
SE8205404L (sv) 1983-03-23
SE8205404D0 (sv) 1982-09-21
NZ201864A (en) 1985-12-13
US4497826A (en) 1985-02-05
NL8203594A (nl) 1983-04-18
SE462781B (sv) 1990-09-03
FR2513117B1 (fr) 1986-01-24
DE3235093C2 (enExample) 1988-12-29
DE3235093A1 (de) 1983-04-07
JPH0216284B2 (enExample) 1990-04-16
CH650926A5 (de) 1985-08-30
GB2106388B (en) 1986-03-26
AU8857882A (en) 1983-03-31
FR2513117A1 (fr) 1983-03-25
NL189648B (nl) 1993-01-18
AU575267B2 (en) 1988-07-21
GB2106388A (en) 1983-04-13
AU6750187A (en) 1987-04-16
IT8268118A0 (it) 1982-09-21
BE894451A (fr) 1983-03-21
AU556542B2 (en) 1986-11-06

Similar Documents

Publication Publication Date Title
NL189648C (nl) Farmaceutisch preparaat met werking op het centrale zenuwstelsel op basis van 3-(3,4-dihydroxyfenyl)-serine en een decarboxylase-remmer.
FI864611A7 (fi) Foerfarande foer framstaellning av tiazolo/4,5-c/kinoliner.
FI864237L (fi) Foerfarande foer framstaellning av 1,6-diklor-1,6-dideoxi- -d-fruktofuranosyl-4-klor-4-deoxi- -galaktopyranosider.
FI892534A0 (fi) Foerfarande foer framstaellning av 1,3-dioler av epoxider.
FI863904A0 (fi) Foerfarande foer framstaellning av 2-substituerade-e-fusionerade-(1,2,4)triazolo-(1,5-c) pyrimidiner.
FI864845A0 (fi) Anordning foer utdelning av servetter.
DE3686545D1 (de) Herbizide 1,2,4-triazol-3-carboxamide.
FI861416L (fi) Foerfarande foer framstaellning av farmakologiskt aktiva 2,3,4,5-tetrahydro-lh-3-benzazepiner.
FI892841A7 (fi) Krets foer maetning av spaenningsfallet mellan svetselektroderna i en mostaondssvetsmaskin.
FI885582A7 (fi) Dubbelriktad kontrolleringssignaler givande bus-interfaceanordning foer oeverfoering av signaler mellan tvao bussystem.
FI892387A0 (fi) Mellanprodukter foer framstaellning av 1,4-dihydro-4-oxokinolin-3-karboxylsyraestrar.
FI880552A7 (fi) Substituerade 2,6-substituerade pyridinfoereningar.
FI881829A0 (fi) 1,3-dioxaner.
FI86060B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,4-naftalendioner.
FI880921A0 (fi) Saett foer aotervinning av vaerme ur heta processgaser.
FI861275A7 (fi) Foerfarande foer framstaellning av farmakologiskt aktiva 16,17-asetalsubstituerade androstan-17 -karboxylsyraestrar.
FI855182A0 (fi) Foerfarande foer framstaellning av 1,3 -disubstituerade tetrahydropyridiner.
FI865244A0 (fi) Foerfarande foer framstaellning av optiskt aktiva 2-klor-12-(3-dimetylamino-2-metylpropyl)-12h-dibenzo-/d,g//1,3,6/ dioxazociner.
FI883256A0 (fi) Flervaerd meningokockvaccin av klass 1 yttermembranprotein.
FI894455A0 (fi) 1,4-dihydropyridinderivat.
FI880417A7 (fi) Foerfarande foer framstaellning av 14,15-substituerade lanosteroler.
FI865158A7 (fi) 1-h-pyrido/3,2//1,4/-tiaziner.
FI893714A7 (fi) 2-amino-4-morfolino-6-propyl -1,3,5-triaziner.
ES2015605B3 (es) 3,4-dihidro-2h-piranos.
FI890658L (fi) Foerfarande foer framstaellning av 1,2-disulfonfoereningar.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 20020916